U.S. needs market-driven regulatory framework, von Eschenbach says

04/9/2013 | American City Business Journals

Medical device, diagnostics and biotech firms should collaborate and share intellectual property early to better address the complicated health problems they are aiming to treat, former FDA director Dr. Andrew von Eschenbach said in a speech Monday in Massachusetts. Von Eschenbach also urged that changes be made to the FDA, including adding a layer of regulation driven by industry.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ